CD79B and B-cell chronic lymphocytic leukemia: Such an effect is in line with our finding that EC-7072 rapidly reduces the surface expression of BCR subunits (CD79B and IgM), although the precise role of these molecules in the activity of the compound in CLL cells remains to be determined.